HÉPATICA LTD

Company Registration Number:
SC739834 (Scotland)

Unaudited abridged accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

HÉPATICA LTD

Contents of the Financial Statements

for the Period Ended 31 July 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

HÉPATICA LTD

Company Information

for the Period Ended 31 July 2024




Director: Mohamed Bekheit
Chaimaa Khaled
Registered office: 60
King's Gate
Aberdeen
GB-SCT
AB15 4EP
Company Registration Number: SC739834 (Scotland)

HÉPATICA LTD

Directors' Report Period Ended 31 July 2024

The directors present their report with the financial statements of the company for the period ended 31 July 2024

Principal Activities

Specialist medical services (this year almost no activity)

Directors

The directors shown below have held office during the whole of the period from 01 August 2023 to 31 July 2024
Mohamed Bekheit
Chaimaa Khaled

This report was approved by the board of directors on 10 August 2024
And Signed On Behalf Of The Board By:

Name: Mohamed Bekheit
Status: Director

HÉPATICA LTD

Profit and Loss Account

for the Period Ended 31 July 2024


Notes

2024
£

2023
£
Gross Profit or (Loss) 391 0
Operating Profit or (Loss) 391 0
Profit or (Loss) Before Tax 391 0
Profit or (Loss) for Period 391 0

The notes form part of these financial statements

HÉPATICA LTD

Balance sheet

As at 31 July 2024


Notes

2024
£

2023
£
Fixed assets
Intangible assets: 1
Total fixed assets: 1
Current assets
Debtors: 4 366
Total current assets: 366
Net current assets (liabilities): 366
Total assets less current liabilities: 366 1
Total net assets (liabilities): 366 1

The notes form part of these financial statements

HÉPATICA LTD

Balance sheet continued

As at 31 July 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 365
Shareholders funds: 366 1

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 10 August 2024
And Signed On Behalf Of The Board By:

Name: Mohamed Bekheit
Status: Director

The notes form part of these financial statements

HÉPATICA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HÉPATICA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 2 2

HÉPATICA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 3. Off balance sheet disclosure

    No

HÉPATICA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 4. Debtors

    This amount I paid to the company from my personal account to pay for registration with the Medical Defence Union for the private activity cover and expenses for ICO and company house